<DOC>
	<DOC>NCT00633126</DOC>
	<brief_summary>The purpose of this study is to determine the pharmacokinetics of ceftaroline in pediatric subjects</brief_summary>
	<brief_title>Pharmacokinetics of Ceftaroline in Subjects 12 to 17 Years of Age</brief_title>
	<detailed_description>The purpose of this study is to determine the pharmacokinetics profile of ceftaroline in pediatric subjects</detailed_description>
	<mesh_term>Cephalosporins</mesh_term>
	<criteria>Hospitalized and receiving antibiotic therapy for treatment of a suspected infection of any type Body mass index (weight [kg]/height squared [m2]) of no more than 30 Males and females between 12 and 17 years of age, inclusive History of any hypersensitivity or allergic reaction to any Î²lactam antimicrobial Past or current history of epilepsy or seizure disorder Critically ill or unstable patients</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>PK</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>